Suppr超能文献

血红素耦合铁(III)-氢氧化物纳米颗粒在 Caco-2 细胞中的摄取增加。

Hemin-coupled iron(III)-hydroxide nanoparticles show increased uptake in Caco-2 cells.

机构信息

Biopharmacy and Pharmaceutical Technology, Institute of Pharmacy and Biochemistry, Johannes Gutenberg University, Mainz, Germany.

出版信息

J Pharm Pharmacol. 2011 Dec;63(12):1522-30. doi: 10.1111/j.2042-7158.2011.01356.x. Epub 2011 Oct 11.

Abstract

OBJECTIVES

The absorption of commonly used ferrous iron salts from intestinal segments at neutral to slightly alkaline pH is low, mainly because soluble ferrous iron is easily oxidized to poorly soluble ferric iron and ferrous iron but not ferric iron is carried by the divalent metal transporter DMT-1. Moreover, ferrous iron frequently causes gastrointestinal side effects. In iron(III)-hydroxide nanoparticles hundreds of ferric iron atoms are safely packed in nanoscaled cores surrounded by a solubilising carbohydrate shell, yet bioavailability from such particles is insufficient when compared with ferrous salts. To increase their intestinal uptake iron(III)-hydroxide nanoparticles were coupled in this study with the protoporphyrin hemin, which undergoes carrier-mediated uptake in the intestine.

METHODS

Uptake of iron(III)-hydroxide nanoparticles with hemin covalently coupled by DCC reaction was measured in Caco-2 cells with a colorimetric assay and visualized by transmission electron microscopy.

KEY FINDINGS

Nanoparticles were taken up by carrier-mediated transport, since uptake was temperature-dependent and increased with an increasing hemin substitution grade. Furthermore, uptake decreased with an increasing concentration of free hemin, due to competition for carrier-mediated uptake.

CONCLUSIONS

Hemin-coupled iron(III)-hydroxide nanoparticles were carried by a heme specific transport system, probably via receptor mediated endocytosis. It can be expected that this system shows improved absorption of iron compared with uncoupled iron(III)-hydroxide nanoparticles, which exist on the market today.

摘要

目的

在中性到微碱性 pH 值下,常用的二价铁盐从肠道段的吸收较低,主要是因为可溶性二价铁很容易被氧化成难溶性三价铁,而只有二价铁是由二价金属转运蛋白 DMT-1 携带。此外,二价铁经常引起胃肠道副作用。在三价铁-氢氧化物纳米颗粒中,数百个三价铁原子安全地包裹在纳米级核心中,周围是可溶解的碳水化合物外壳,但与二价铁盐相比,从这种颗粒中获得的生物利用度仍然不足。为了增加它们的肠道摄取,本研究将三价铁-氢氧化物纳米颗粒与原卟啉血红素偶联,血红素在肠道中通过载体介导摄取。

方法

通过比色法测量 DCC 反应共价偶联血红素的三价铁-氢氧化物纳米颗粒在 Caco-2 细胞中的摄取,并通过透射电子显微镜进行可视化。

主要发现

纳米颗粒通过载体介导的运输被摄取,因为摄取是温度依赖性的,并随着血红素取代度的增加而增加。此外,由于载体介导摄取的竞争,摄取随着游离血红素浓度的增加而减少。

结论

血红素偶联的三价铁-氢氧化物纳米颗粒由血红素特异性转运系统携带,可能通过受体介导的内吞作用。可以预期,与今天市场上存在的未偶联的三价铁-氢氧化物纳米颗粒相比,这种系统显示出改善的铁吸收。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验